NEVVI Medicare utilization intelligence

← back

KORRAPATI, VIJAYAM.D. NPI 1033186713 Clinician

Hematology-Oncology · WEST COLUMBIA, SC

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 34 years since medical school (class of 1992, self-reported to CMS)
Location WEST COLUMBIA, SC · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 88 codes billed · 179,673 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
LEXINGTON HEALTH INC
2021–2026
LEXINGTON COUNTY HEALTH SERVICES DISTRICT INC
2019–2021

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2020-11

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1453 Injection, fosaprepitant, 1 mg
J0897 Injection, denosumab, 1 mg
J9299 Injection, nivolumab, 1 mg
J0185 Injection, aprepitant, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J9267 Injection, paclitaxel, 1 mg
J9312 Injection, rituximab, 10 mg
J9171 Injection, docetaxel, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J1626 Injection, granisetron hydrochloride, 100 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J0461 Injection, atropine sulfate, 0.01 mg
36415 Insertion of needle into vein for collection of blood sample
J9041 Injection, bortezomib, 0.1 mg
J9035 Injection, bevacizumab, 10 mg
J9190 Injection, fluorouracil, 500 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
80048 Blood test, basic group of blood chemicals (calcium, total)
80076 Liver function blood test panel
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
80053 Blood test, comprehensive group of blood chemicals
96375 Injection of additional new drug or substance into vein
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
96413 Administration of chemotherapy into vein, 1 hour or less
J9181 Injection, etoposide, 10 mg
96372 Injection of drug or substance under skin or into muscle
J9206 Injection, irinotecan, 20 mg
J9045 Injection, carboplatin, 50 mg
82728 Ferritin (blood protein) level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
A9595 Piflufolastat f-18, diagnostic, 1 millicurie
83540 Iron level
83550 Iron binding capacity
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
83735 Magnesium level
Q5122 Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J0640 Injection, leucovorin calcium, per 50 mg
96415 Administration of chemotherapy into vein, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
J3475 Injection, magnesium sulfate, per 500 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J9060 Injection, cisplatin, powder or solution, 10 mg
74177 Ct scan of abdomen and pelvis with contrast
71260 Ct scan of chest with contrast
84443 Blood test, thyroid stimulating hormone (tsh)
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
84439 Thyroxine (thyroid chemical), free
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
J7030 Infusion, normal saline solution , 1000 cc
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96411 Administration of additional new drug or substance into vein using push technique
82565 Blood creatinine level
96416 Administration of prolonged chemotherapy into vein
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96360 Infusion into a vein for hydration, 31-60 minutes
84153 Psa (prostate specific antigen) measurement, total
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J7050 Infusion, normal saline solution, 250 cc
82378 Carcinoembryonic antigen (cea) protein level
J1200 Injection, diphenhydramine hcl, up to 50 mg
71250 Ct scan of chest without contrast
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
83615 Lactate dehydrogenase (enzyme) level
82024 Adrenocorticotropic hormone (acth) level
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function
81003 Automated urinalysis test
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
93971 Ultrasound study of one arm or leg veins with compression and maneuvers
96409 Administration of chemotherapy into vein using push technique
J3490 Unclassified drugs
78816 Nuclear medicine study whole body with ct scan
93970 Ultrasound study of arm or leg veins with compression and maneuvers
96523 Irrigation of implanted venous access drug delivery device
74176 Ct scan of abdomen and pelvis without contrast
96374 Injection of drug or substance into vein
93880 Ultrasound of both sides of head and neck blood flow

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.